The 20 Best Non-Alcoholic Fatty Liver Disease Doctors Near Me in Baltimore, MD

James Tonascia is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Tonascia is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Deep Brain Stimulation.

Saleh Alqahtani is a Gastroenterologist practicing medicine in Baltimore, Maryland. Dr. Alqahtani is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Obesity, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Dr. Benjamin Philosophe is the surgical director of the Johns Hopkins Comprehensive Transplant Center. He also serves as the lead transplant surgeon at Sibley Memorial Hospital’s Hepatology Multidisciplinary Center. Dr. Philosophe was the first physician to perform robotic total right and total left hepatic resections in the state of Maryland. He has expanded the application of minimally invasive surgical approaches to other hepatobiliary diseases and has improved outcomes and reduced effects of surgery on these patients. Dr. Philosophe practices out of The Johns Hopkins Hospital in Baltimore, Md., as well as Johns Hopkins Community Physician locations in Bethesda, Md. and Lutherville, Md. He is also affiliated with Suburban Hospital and Johns Hopkins Howard County Medical Center. Dr. Philosophe has a wide range of expertise, including cirrhosis; hepatic surgery, hepatitis, hepatobiliary conditions and surgeries; biliary tract surgery and hepatopancreatobiliary surgery; laparoscopic surgeries; vascular surgery; and robotic surgeries. He also has an expertise in various kinds of transplant surgeries, such as kidney, live donor liver, liver and pancreas, as well as various kinds of cancer, such as bile duct, gallbladder, hepatocellular, liver and pancreatic. Dr. Philosophe earned his medical degree from Boston University School of Medicine. He completed a residency in general surgery at Barnes-Jewish Hospital, followed by a liver transplantation fellowship at the University of Toronto. Dr. Philosophe also completed a transplant surgery fellowship at the University of Maryland, where he went on to work as a professor of surgery and the head of liver transplantation and hepatobiliary surgery. Dr. Philosophe is a member of the American Board of Surgery, the Clinical Robotic Surgery Association, the American Society of Transplant Surgeons, the Transplantation Society and the International Liver Transplantation Society. He has earned a Super Doctors Award in general surgery from the Washington Post Magazine, as well as a Top Doctor Award for hepatobiliary surgery and transplant specialists from Baltimore Magazine. Dr. Philosophe has also been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. Dr. Philosophe has contributed to numerous publications and presentations. His research interests include uncovering the mechanisms that contribute to transplant rejection and determining characteristics that can be used to better predict donor organ function. He has completed pioneering work in developing a scoring system called the Maryland Aggregate Pathology Index (MAPI), which is used by transplant surgeons worldwide to assess the likelihood of a deceased donor’s kidney function after transplantation. MAPI has increased the utilization of donor kidneys and saved many lives. Dr. Philosophe is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hepatitis, End-Stage Renal Disease (ESRD), Liver Failure, Liver Transplant, and Kidney Transplant. Dr. Philosophe is board certified in American Board Of Surgery.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Dr. Ma is an assistant professor of medicine at the Johns Hopkins University School of Medicine. She received her medical degree from the University of Michigan Medical School and completed her internal medicine residency at the University of Pennsylvania. Following her residency, she performed a fellowship in transplant hepatology at the Johns Hopkins University School of Medicine. Dr. Ma specializes in liver disorders including alcoholic liver disease, viral hepatitis, non-alcoholic fatty liver disease, metabolic liver disorders, as well as the care of patients after liver transplant. Dr. Ma also has interests in medical education and currently serves as the Associate Program Director of the Gastroenterology Fellowship. Dr. Ma is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Cirrhosis, Hepatitis C, Endoscopy, and Gastrectomy. Dr. Ma is board certified in American Board Of Internal Medicine.

Alexandra (Aly) Strauss is a transplant hepatologist who treats patients with acute and chronic liver disease, such as cirrhosis and liver cancer. Dr. Strauss completed medical school at the University of South Florida (USF), where she continued for internal medicine residency training and served as chief resident. She then went to The Johns Hopkins University for fellowship training in gastroenterology, followed by a fellowship in transplant hepatology. Her research training began when she completed a master’s degree in industrial/systems engineering at USF. Later, at the Johns Hopkins Bloomberg School of Public Health, she earned her Ph.D. in clinical investigation. Dr. Strauss’s research focus is on the use of systems engineering and data science to improve access to liver transplantation. She serves as core faculty in the Johns Hopkins University Malone Center for Engineering in Healthcare and is a faculty member in the Center for Data Science in Emergency Medicine. Recent News Articles and Media Coverage What Does AI Mean for GI, What does AI mean for GI? - American Gastroenterological Association (07/03/2023) Selected Publications Vong, Tyrus, Nicholas Rizer, Vedant Jain, Valerie L. Thompson, Mark Dredze, Eili Y. Klein, Jeremiah S. Hinson, et al. “Automated Identification of Incidental Hepatic Steatosis on Emergency Department Imaging Using Large Language Models.” Hepatology Communications 9, no. 3 (March 1, 2025). https://doi.org/10.1097/HC9.0000000000000638. Mankowski, Michal A., Sunjae Bae, Alexandra T. Strauss, Bonnie E. Lonze, Babak J. Orandi, Darren Stewart, Allan B. Massie, et al. “Generalizability of Kidney Transplant Data in Electronic Health Records - The Epic Cosmos Database vs the Scientific Registry of Transplant Recipients.” American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, November 15, 2024. https://doi.org/10.1016/j.ajt.2024.11.008. Xu, Jingzhi, Michal Mankowski, Karen B. Vanterpool, Alexandra T. Strauss, Bonnie E. Lonze, Babak J. Orandi, Darren Stewart, et al. “Trials and Tribulations: Responses of ChatGPT to Patient Questions about Kidney Transplantation.” Transplantation 109, no. 3 (March 1, 2025): 399–402. https://doi.org/10.1097/TP.0000000000005261. Strauss AT, Morgan C, El Khuri C, Slogeris B, Smith AG, Klein E, Toerper M, Peterson S, Gurses AP, DeAngelo A, Debraine, A, Levin S, Hinson J. Human-centered design and usability evaluation of LOOP, a patient outcomes-driven feedback platform for emergency medicine clinicians. JMIR Human Factors. 2022;9(1):e30130; *corresponding author. Strauss AT, Yeh J, Martinez D, Yanokyan G, Yoder J, Nehra R, Feller T, Bull-Henry K, Stein E, Hsu L, Al-Grain H, Zabko C, Fain C. A patient-centered framework for health systems engineering in gastroenterology: improving inpatient colonoscopy bowel preparation. BMC Gastroenterol. 2021;21(1):89;. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Hepatitis C, Hepatitis, Liver Failure, Liver Transplant, and Endoscopy. Dr. Strauss is board certified in American Board Of Internal Medicine.

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Hypogonadism, Testicular Failure, Eunuchoidism Familial Hypogonadotropic, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT). Dr. Dobs is board certified in American Board Of Internal Medicine.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Donner is board certified in American Board Of Internal Medicine.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, and Papillary Thyroid Cancer. Dr. Ball is board certified in American Board Of Internal Medicine.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, and Medullary Thyroid Carcinoma. Dr. Cooper is board certified in American Board Of Internal Medicine.

Dr. Paul Ladenson is a professor of medicine at the Johns Hopkins University School of Medicine. He is also a professor of oncology; pathology; and radiology and radiological science. His areas of clinical expertise include Thyroid diseases, Endocrine & Metabolic disorders. Dr. Ladenson is the John Eager Howard Professor of Endocrinology and Metabolism. He earned his M.D. from Harvard Medical School. He completed his residency and performed a fellowship in endocrinology, diabetes and metabolism at Massachusetts General Hospital. Dr. Ladenson's research interests include cardiac actions of thyroid hormone, thyroid cancer and thyroid hormone analogs. He was recognized with the Lewis E. Braverman Lectureship Award at the 82nd Annual Meeting of the American Thyroid Association (ATA) in 2012. Dr. Ladenson is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Thyroid Nodule, Adrenal Insufficiency Pediatric, Secondary Adrenal Insufficiency, PIK3CA-Related Overgrowth Spectrum, and Thyroidectomy. Dr. Ladenson is board certified in American Board Of Internal Medicine.

Dr Paul is a Transplant Surgeon practicing medicine in Baltimore, Maryland. Dr. Paul is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.

Jeffrey Hirsch is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Hirsch is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Ascites, Visceromegaly, Retroversion of the Uterus, and Angiomyoma.

Kashif Munir is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Munir is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Ahmed Rafay is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Rafay is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Visceromegaly, and Nasal Flaring.

Dr. Homeira Zahiri is a Clinical Associate in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She received her medical degree from Islamic Azad University - Tehran Branch. She performed residencies at Tehran University of Medical Sciences in pathology, University of Nebraska Medical Center in nuclear medicine and Creighton University School of Medicine in radiology. Dr. Zahiri completed a body imaging fellowship at Johns Hopkins Medicine. Dr. Zahiri is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, ALK-Positive Non-Small Cell Lung Cancer, and Visceromegaly. Dr. Zahiri is board certified in American Board Of Radiology and American Board Of Nuclear Medicine.

Dr. Christopher Testa specializes in diagnostic radiology, with 10 years of experience in hospital and private practice settings. Dr. Testa earned his medical degree from Georgetown University School of Medicine. After completing an internship in internal medicine and residency in diagnostic radiology at Saint Vincent Hospital in Worcester, Mass., where he also served as chief resident, he went on to a fellowship in cross-sectional body imaging at the Johns Hopkins Hospital. Dr. Testa joined the Community Radiology Division in the NCR in November 2021. Dr. Testa is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Nasal Flaring, and Gallbladder Disease. Dr. Testa is board certified in American Board Of Radiology.

Dr. Russell Wesson is the Surgical Director of Kidney Transplantation and a liver and kidney transplant surgeon at the Johns Hopkins School of Medicine. His areas of clinical expertise include Liver, Kidney and Pancreas Transplantation, Hepatobiliary surgery, Living Liver and Kidney donation and Transplantation for Colorectal Metastasis. Dr. Wesson completed his General Surgery Residency in 2016 at the Johns Hopkins Hospital. He was an intern at Johns Hopkins in 2009 after receiving his medical degree from the University of Cape Town, South Africa. After his residency, Dr. Wesson completed the American Society of Transplant Surgery accredited Fellowship in Abdominal Transplant and Hepatobiliary Surgery at Johns Hopkins. He continued on faculty within the division of transplant surgery. Dr. Wesson's academic and research focuses on basic and translational research within the context of liver and kidney transplantation and organ injury. He is active as a principle investigator on multiple clinical trials investigating novel immunosuppressive agents. He is a member of the American Society of Transplant Surgery as well as the American Transplantation Society. Dr. Wesson is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Chronic Antibody-Mediated Rejection, Hepatitis, Kidney Transplant, and Liver Transplant. Dr. Wesson is board certified in American Board Of Surgery.